Neglected Tropical Diseases Diagnosis - Global Strategic Business Report

The global market for Neglected Tropical Diseases Diagnosis was estimated at US$5.4 Billion in 2025 and is projected to reach US$6.7 Billion by 2032, growing at a CAGR of 3.3% from 2025 to 2032. This comprehensive report provides an in-depth analysis of market trends, drivers, and forecasts, helping you make informed business decisions.

Global Neglected Tropical Diseases Diagnosis Market - Key Trends and Drivers Summarized

Why Is Neglected Tropical Diseases Diagnosis Crucial for Global Health?

Neglected Tropical Diseases (NTDs) encompass a range of infectious diseases that predominantly affect populations in low-income regions. Accurate diagnosis of NTDs is critical for controlling and eradicating these diseases, which include conditions like dengue, leishmaniasis, Chagas disease, and schistosomiasis. Early and precise diagnosis helps prevent complications, reduces transmission, and aids in effective treatment. Traditionally, diagnosing NTDs has been challenging due to limited resources, lack of infrastructure, and the need for specialized equipment. However, innovations in diagnostic technologies, such as rapid diagnostic tests (RDTs), molecular assays, and point-of-care devices, are transforming NTD diagnosis by making it faster, more accurate, and accessible in remote areas.

What Are the Key Segments in the NTD Diagnosis Market?

Diagnostic techniques include serological tests, molecular tests, and imaging-based diagnostics. Serological tests, which detect antibodies or antigens, are widely used for diseases like dengue and leishmaniasis, while molecular tests, such as polymerase chain reaction (PCR), are preferred for their accuracy in detecting diseases like Chagas and schistosomiasis. In terms of disease type, the market covers parasitic, viral, and bacterial NTDs, with parasitic NTDs being the largest segment due to their prevalence in affected regions. Major end-users of NTD diagnostics include hospitals, clinics, public health laboratories, and research institutions that are focused on improving disease surveillance and treatment strategies.

How Are Technological Innovations Enhancing NTD Diagnosis?

Technological advancements are at the forefront of improving NTD diagnosis. Rapid diagnostic tests (RDTs) have emerged as a cost-effective solution, offering results within minutes and facilitating quick decision-making in remote areas with limited healthcare infrastructure. Molecular diagnostics, such as real-time PCR and loop-mediated isothermal amplification (LAMP), offer high sensitivity and specificity, making them essential for accurate disease detection. Digital health tools, including mobile-based diagnostic kits and AI-powered diagnostic algorithms, are also being deployed to enhance disease detection, data collection, and reporting in NTD-affected regions. These technologies not only improve diagnosis but also contribute to global efforts toward NTD elimination.

What Factors Are Driving the Growth in the Neglected Tropical Diseases Diagnosis Market?

The growth in the Neglected Tropical Diseases Diagnosis market is driven by several factors, including the increasing burden of NTDs in low- and middle-income countries and the urgent need for accurate, affordable diagnostics. Government and non-governmental organizations' efforts to control and eliminate NTDs through better surveillance and diagnosis have significantly boosted the demand for innovative diagnostic tools. Technological advancements, such as portable diagnostic devices and point-of-care testing, have made NTD diagnosis more accessible, even in resource-constrained settings. Additionally, international funding from global health initiatives, such as the World Health Organization and the Bill & Melinda Gates Foundation, is promoting research and development in NTD diagnostics. The increasing focus on integrating diagnostics into primary healthcare systems is also driving market growth.

Report Scope

The report analyzes the Neglected Tropical Diseases Diagnosis market, presented in terms of market value (US$). The analysis covers the key segments and geographic regions outlined below:

• Segments: Method (Conventional, Molecular / Modern); Service Type (Centralized, Point of Care); End-Use (Clinical Labs, Hospitals & Clinics, Home Healthcare).
• Geographic Regions/Countries: World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Key Insights:

• Market Growth: Understand the significant growth trajectory of the Conventional Method segment, which is expected to reach US$3.7 Billion by 2032 with a CAGR of 2.8%. The Molecular / Modern Method segment is also set to grow at 3.9% CAGR over the analysis period.
• Regional Analysis: Gain insights into the U.S. market, valued at $1.7 Billion in 2025, and China, forecasted to grow at an impressive 6.0% CAGR to reach $1.5 Billion by 2032. Discover growth trends in other key regions, including Japan, Canada, Germany, and the Asia-Pacific.

Why You Should Buy This Report:

• Detailed Market Analysis: Access a thorough analysis of the Global Neglected Tropical Diseases Diagnosis Market, covering all major geographic regions and market segments.
• Competitive Insights: Get an overview of the competitive landscape, including the market presence of major players across different geographies.
• Future Trends and Drivers: Understand the key trends and drivers shaping the future of the Global Neglected Tropical Diseases Diagnosis Market.
• Actionable Insights: Benefit from actionable insights that can help you identify new revenue opportunities and make strategic business decisions.

Key Questions Answered:

• How is the Global Neglected Tropical Diseases Diagnosis Market expected to evolve by 2032?
• What are the main drivers and restraints affecting the market?
• Which market segments will grow the most over the forecast period?
• How will market shares for different regions and segments change by 2032?
• Who are the leading players in the market, and what are their prospects?

Report Features:

• Comprehensive Market Data: Independent analysis of annual sales and market forecasts in US$ Million from 2025 to 2032.
• In-Depth Regional Analysis: Detailed insights into key markets, including the U.S., China, Japan, Canada, Europe, Asia-Pacific, Latin America, Middle East, and Africa.
• Company Profiles: Coverage of players such as Abbott Laboratories, Beckman Coulter/Danaher, Bio-Rad Laboratories, Inc., Coris Bioconcept SPRL, DiaSys Diagnostic Systems GmbH and more.
• Complimentary Updates: Receive free report updates for one year to keep you informed of the latest market developments.

Some of the companies featured in this Neglected Tropical Diseases Diagnosis market report include:

• Abbott Laboratories
• Beckman Coulter/Danaher
• Bio-Rad Laboratories, Inc.
• Coris Bioconcept SPRL
• DiaSys Diagnostic Systems GmbH
• F. Hoffmann-La Roche Ltd.
• Genome Diagnostics Pvt. Ltd
• InBios International, Inc.
• Life Technology
• Novartis Diagnostics., Ltd.
• Omega Diagnostics Group PLC
• Ortho-Clinical Diagnostics
• Oscar Medicare Pvt Ltd.
• Premier Medical Corporation Ltd.
• Siemens Healthcare
• Thermo Fisher Scientific, Inc.
• Wako Chemicals, Inc.
• ZeptoMetrix

Domain Expert Insights

This market report incorporates insights from domain experts across enterprise, industry, academia, and government sectors. These insights are consolidated from multilingual multimedia sources, including text, voice, and image-based content, to provide comprehensive market intelligence and strategic perspectives. As part of this research study, the publisher tracks and analyzes insights from 5,916 domain experts. Clients may request access to the network of experts monitored for this report, along with the online expert insights tracker.